First-half results met expectations, with profits and margins up on strong innovation and transformation benefits. Consumer Care, especially Beauty Actives, led growth, while Pharma Solutions is set to improve in H2. Full-year guidance and 2028 targets are reaffirmed.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.